CANY
CAH icon

Caxton Associates (New York)’s Cardinal Health CAH Stock Holding History

Caxton Associates (New York)’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,554
Closed -$2.86M – 487
2024
Q1 		$2.86M Buy
25,554
+9,121
+56% +$984K 0.16% 85
2023
Q4 		$1.66M Buy
16,433
+7,156
+77% +$710K 0.09% 147
2023
Q3 		$805K Sell
9,277
-13,539
-59% -$1.22M 0.11% 186
2023
Q2 		$2.16M Buy
22,816
+5,959
+35% +$503K 0.32% 61
2023
Q1 		$1.27M Sell
16,857
-16,849
-50% -$1.27M 0.19% 108
2022
Q4 		$2.59M Buy
33,706
+18,200
+117% +$1.38M 0.17% 32
2022
Q3 		$1.03M Sell
15,506
-4,864
-24% -$308K 0.14% 105
2022
Q2 		$1.06M Buy
+20,370
New +$1.16M 0.1% 110
2020
Q2 		– Sell
-17,303
Closed -$830K – 465
2020
Q1 		$830K Buy
+17,303
New +$898K 0.15% 78
2019
Q1 		– Sell
-6,203
Closed -$277K – 385
2018
Q4 		$277K Buy
+6,203
New +$323K 0.04% 200
2014
Q2 		– Sell
-50,000
Closed -$3.4M – 186
2014
Q1 		$3.5M Sell
50,000
-10,901
-18% -$758K 0.21% 86
2013
Q4 		$4.07M Buy
+60,901
New +$3.72M 0.13% 80

Other funds holding CAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Caxton Associates (New York)'s CAH Position: Q2 2024 in Review

Caxton Associates (New York) sold out of Cardinal Health (CAH) in Q2 2024, closing a stake of 25,554 shares — an estimated $2.86M sold.

Caxton Associates (New York) first reported a position in CAH in Q4 2013 and held it in 12 quarters. The position peaked at $4.07M in Q4 2013. 1,009 funds tracked by Wall St. Rank hold CAH as of Q2 2024.

  • Caxton Associates (New York) reported no remaining Cardinal Health position as of Q2 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 25,554 Cardinal Health shares in Q2 2024, an estimated $2.86M.
  • Caxton Associates (New York) first reported a position in Cardinal Health in Q4 2013 and held it in 12 quarters.
  • Caxton Associates (New York)'s Cardinal Health position peaked at $4.07M in Q4 2013.
  • 1,009 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2024.

Based on Caxton Associates (New York)'s 13F filing for Q2 2024, filed 14 Aug 2024.